Development of linear β-turn inducers containing peptides as arc mimetics with DNA topological and sequence selectivity
Loading...
Identifiers
ISSN: 0223-5234
E-ISSN: 1768-3254
Publication date
Advisors
Tutors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
In general, biological macromolecules such as proteins interact with the major groove of the ds-DNA via hydrogen bonds formation, thus blocking the site access of TFs to specific DNA sequences. Considering that the primary sequence of arc repressor responsible for DNA binding is well-characterized as well as the 3D-conformational requisites for its optimal interactions with the specific DNA base-pairs, a series of well-tailored arc analogues could be designed using computational molecular tools and available structural data. These novel molecular entities have been synthesized following ultrasound assisted-solid phase peptide synthesis (US-SPPS), characterized by NMR experiments and screened for TAGA box selectivity on DNA oligomers using a battery of DNA displacement assays. Data obtained show a clear tendency of peptide ACAS_4 to assume a 3-D β-sheet like structure responsible of the interaction with DNA major groove and to bind selectively to the consensus sequence of DNA. For the best of our knowledge this is the first report on a β-sheet arc mimetic endowed with topological and sequence selectivity for the TAGA box of DNA.
Description
Keywords
Bibliographic citation
Stefanucci, A., Santoro, F., D’Ingiullo, S., Marinaccio, L., Procino, E., Learte-Aymamí, S., Rodriguez, J., Mascareñas, J. L., Amato, J., Arciuolo, V., Randazzo, A., De Rosa, M., Brancaccio, D., Mollica, A., & Carotenuto, A. (2025). DEVELOPMENT OF LINEAR Β-TURN INDUCERS CONTAINING PEPTIDES AS ARC MIMETICS WITH DNA TOPOLOGICAL AND SEQUENCE SELECTIVITY. European Journal Of Medicinal Chemistry, 289, 117423. https://doi.org/10.1016/j.ejmech.2025.117423
Relation
Has part
Has version
Is based on
Is part of
Is referenced by
Is version of
Requires
Publisher version
https://doi.org/10.1016/j.ejmech.2025.117423Sponsors
A.S. acknowledges financial support under the National Recovery and Resilience Plan (PNRR), Mission 4, Component C2, Investment 1.1, Call for tender No. 1409 published on September 14, 2022 by the Italian Ministry of University and Research (MUR), funded by the European Union-NextGenerationEU-Project Title Ultrasonic Technology for the Sustainable Chemical Synthesis of Peptide-based Therapeutics (US4PepTher)-CUP D53D23016950001-Grant Assignment Decree No. 0001384 adopted on 01-09-2023 by the Italian Ministry of Ministry of University and Research (MUR). A.C. acknowledges PRIN2022 (2022LFFPZE) “PROTAC-based approach to develop broad-spectrum antiviral drugs triggering the proteolysis of the main viral protease”.D.B. acknowledges PRIN2022 (20222HMJLN) “Multi-targeting G-quadruplex ligands as innovative chemotherapeutic agents to combat tumor drug resistance (MuTaG4L)”. J.R. acknowledges grants RYC2022-035154-I (funded by MICIU/AEI/10.13039/501100011033 and by FSE+) and PID2023-146174NA-I00 (funded by MICIU/AEI/10.13039/501100011033 and by FEDER, UE).
Rights
© 2025 The Authors. Published by Elsevier Masson SAS. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).
Attribution-NonCommercial-NoDerivatives 4.0 International
Attribution-NonCommercial-NoDerivatives 4.0 International








